» Articles » PMID: 36798815

Editorial: Differential Diagnoses of Thyroid Neoplasms: Molecular and Histological Features and the Impact on Follow-up

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Feb 17
PMID 36798815
Authors
Affiliations
Soon will be listed here.
References
1.
Fresilli D, David E, Pacini P, Del Gaudio G, Dolcetti V, Lucarelli G . Thyroid Nodule Characterization: How to Assess the Malignancy Risk. Update of the Literature. Diagnostics (Basel). 2021; 11(8). PMC: 8391491. DOI: 10.3390/diagnostics11081374. View

2.
Ragusa F, Ferrari S, Elia G, Paparo S, Balestri E, Botrini C . Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer. Int J Mol Sci. 2022; 23(10). PMC: 9144613. DOI: 10.3390/ijms23105731. View

3.
Baldini E, Presutti D, Favoriti P, Santini S, Papoff G, Tuccilli C . In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines. Int J Mol Sci. 2022; 23(7). PMC: 8999125. DOI: 10.3390/ijms23073724. View

4.
Ohori N . Molecular testing and thyroid nodule management in North America. Gland Surg. 2020; 9(5):1628-1638. PMC: 7667110. DOI: 10.21037/gs-2019-catp-26. View

5.
Baldini E, Lauro A, Tripodi D, Pironi D, Amabile M, Ferent I . Thyroid Diseases and Breast Cancer. J Pers Med. 2022; 12(2). PMC: 8876618. DOI: 10.3390/jpm12020156. View